총 702건 중 702건 출력
, 71/71 페이지
-
701
-
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study
-
Pugliese, Daniela;
Privitera, Giuseppe;
Crispino, Federica;
Mezzina, Nicolò
;
Castiglione, Fabiana;
Fiorino, Gionata;
Laterza, Lucrezia;
Viola, Anna;
Bertani, Lorenzo;
Caprioli, Flavio;
Cappello, Maria;
Barberio, Brigida;
Ricci, Chiara;
Balestrieri, Paola;
Daperno, Marco;
Pluchino, Dario;
Rizzello, Fernando;
Scribano, Maria Lia;
Sablich, Renato;
Pastorelli, Luca;
Manguso, Francesco;
Variola, Angela;
Di Sario, Antonio;
Grossi, Laurino;
Armuzzi, Alessandro;
Ribaldone, Davide Giuseppe;
Biscaglia, Giuseppe;
Buda, Andrea;
Mocci, Giammarco;
Viscido, Angelo;
Di Paolo, Maria Carla;
Onali, Sara;
Rodino, Stefano;
Coletta, Marina;
Principi, Mariabeatrice;
Miranda, Agnese;
Amato, Arnaldo;
Bezzio, Cristina;
Petruzzellis, Carlo;
Mazzuoli, Silvia;
Festa, Stefano;
Sartini, Alessandro;
Checchin, Davide;
Fanigliulo, Libera;
Gallina, Sara;
Cesarini, Monica;
Bodini, Giorgia;
Stradella, Davide;
Spagnuolo, Rocco;
Guidi, Luisa;
Savarino, Edoardo;
Scriv;
CEMAD - IBD UNIT, Unità
Operativa Complessa di Medicina Interna e Gastroenterologia, Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario “A. Gemelli” IRCCS, Rome, Italy;
Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università
Cattolica del Sacro Cuore, Rome, Italy;
Riuniti Villa Sofia-Cervello Hospital, Internal Medicine e 2, IBD Unit Palermo, Palermo, Italy;
Department of Biochemical and Clinical Science “L. Sacco” ASST Fatebenefratelli Sacco-University of Milan, Milan, Italy;
Gastroenterology, Federico II University Hospital, Naples, Campania, Italy;
IBD Center, Gastroenterology, Humanitas Clinical and Research Center, IRCCS, Rozzano, Milan, Italy¸ Department of Biomedical Sciences, Humanitas Uni;
(Alimentary pharmacology & therapeutics,
v.56,
2022,
pp.95-109)
-
702
-
Opportunistic testing of <i>BRCA1</i>, <i>BRCA2</i> and mismatch repair genes improves the yield of phenotype driven hereditary cancer gene panels
-
Feliubadaló
, Lí
dia;
Ló
pez‐
Ferná
ndez, Adrià
;
Pineda, Marta;
Dí
ez, Orland;
del Valle, Jesú
s;
Gutié
rrez‐
Enrí
quez, Sara;
Teulé
, Alex;
Gonzá
lez, Sara;
Stjepanovic, Neda;
Salinas, Mó
nica;
Capellá
, Gabriel;
Brunet, Joan;
Lá
zaro, Conxi;
Balmañ
a, Judith;
Campos, Olga;
Carrasco, Estela;
Cuesta, Raquel;
Darder, Esther;
Gadea, Neus;
Gó
mez, Carolina;
Grau, Elia;
Iglesias, Silvia;
Izquierdo, Angel;
Llort, Gemma;
Mené
ndez, Mireia;
Moles‐
Ferná
ndez, Alejandro;
Montes, Eva;
Muñ
oz, Xavier;
Navarro, Matilde;
Ramon y Cajal, Teresa;
Sanz, Judit;
Solanes, Ares;
Stradella, Agostina;
Tornero, Eva;
Torres‐
Esquius, Sara;
Tuset, Noemí
;
Urgell, Gisela;
Velasco, Angela;
Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain;
High Risk and Familial Cancer, Vall d'Hebron Institute of Oncology, Barcelona;
Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain;
Oncogenetics Group, Vall d'Hebron Institute of Oncology Barcelona, Barcelona, Spain;
Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain;
Oncogenetics Group, Vall d'Hebron Institute of Oncology Barcelona, Barcelona, Spain;
Hereditary Cancer Program, Catalan Institute of Oncology, IDIBELL, Hospitalet de Llobregat, Barcelona, Spain;
Hereditary Cancer Program, Catalan Ins;
(International journal of cancer: Journal international du cancer,
v.145,
2019,
pp.2682-2691)

71